Form 4: CFO Sells ABEO Shares for Tax Obligations

Abeona Therapeutics CFO Joseph Vazzano sold 18,666 shares of common stock at a weighted average price of $5.3309 to cover tax obligations from restricted stock vesting.

Summary

• Joseph Walter Vazzano, Chief Financial Officer of Abeona Therapeutics Inc. (ABEO), reported a sale of common stock.
• The transaction occurred on January 22, 2026.
• A total of 18,666 shares were sold at a weighted average price of $5.3309 per share.
• The sale was executed to cover tax obligations associated with the vesting of restricted stock awards.
• Following this transaction, Mr. Vazzano beneficially owns 568,560 shares of common stock directly.

Sentiment

Score: 5

Explanation: The sale of shares by the CFO is a routine transaction to cover tax obligations from restricted stock vesting and does not inherently reflect a positive or negative outlook on the company's performance.

Positives

• The transaction is a routine sale to cover tax obligations, which is a common and expected event for executives receiving equity compensation.

Negatives

• No inherently negative aspects are indicated by this routine tax-related sale.

Future Outlook

NA

Management Comments

• The sale reported was to cover tax obligations associated with the vesting of restricted stock awards.
• The price reported is a weighted average price, with shares sold in multiple transactions at prices ranging from $5.33 to $5.38 inclusive.
• The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request.

Industry Context

This Form 4 filing details a routine insider transaction, which is common across all industries when executives receive equity compensation that vests and triggers tax liabilities. It does not provide specific industry-wide insights.

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a routine, tax-related insider sale and not indicative of a change in company fundamentals or management's confidence.

Key Dates

Recommendation

The sale of shares by the Chief Financial Officer is a common practice to cover tax liabilities arising from the vesting of restricted stock awards. This transaction is not indicative of a change in the company's fundamentals or management's confidence, thus a 'hold' recommendation is maintained based solely on this filing.

Keywords

ABEONA THERAPEUTICS, ABEO, Form 4, Insider Trading, Stock Sale, CFO, Joseph Vazzano, Restricted Stock, Tax Obligations